UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000017737
Receipt No. R000020547
Scientific Title Effect of the long-term intake of bitter gourd (Momordica charantia) containing food on blood glucose level in human.
Date of disclosure of the study information 2015/12/25
Last modified on 2016/01/07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effect of the long-term intake of bitter gourd (Momordica charantia) containing food on blood glucose level in human.
Acronym Effect of the long-term intake of bitter gourd (Momordica charantia) containing food on blood glucose level in human.
Scientific Title Effect of the long-term intake of bitter gourd (Momordica charantia) containing food on blood glucose level in human.
Scientific Title:Acronym Effect of the long-term intake of bitter gourd (Momordica charantia) containing food on blood glucose level in human.
Region
Japan

Condition
Condition high normal blood glucose and borderline hyperglycemia
Classification by specialty
Endocrinology and Metabolism Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To confirm the effect of 12-week intake of bitter gourd containing beverages on blood glucose level.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Area under the curve of blood glucose level after ingestion of rice
Key secondary outcomes Blood glucose level at each blood sampling time after ingestion of rice, Active blood GLP-1 level, IRI, Fasting blood glucose level, HOMA-IR

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification NO
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment Numbered container method

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 Intake 250ml of bitter gourd containing beverage for 12 weeks once a day
Interventions/Control_2 Intake 250ml of polydextrose for 12 weeks once a day
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
65 years-old >
Gender Male and Female
Key inclusion criteria (1)Healthy males and females aged 20 to less than 65 years old.

(2)Subjects whose fasting blood glulose levels are ranged from 100mg/dL to less than 126 mg/dL.

(3)Subjects who can make self-judgment and are voluntarily giving written informed consent.
Key exclusion criteria (1)Subjects who take continuous medical treatment.
(2)Subjects who are contracting diabetes (based on diagnosis criterion of The Japan Diabetes Society)
(3)Subjects who constantly use supplements and/or functional foods (including Food for Specified Health Uses) affecting the test results.
(4)Subjects who have contracted or are contracting heart disease, liver disease, kidney disease and digestive disease.
(5)Subjects who are pregnant or have possibility to bocome pregnant or planning to become pregnant during the study or breast-feeding woman.
(6)Subjects who drink alcohol a lot
(7)Subjects who have an extremely irregular diet habit or alternative work schedule or work on midnight shift
(8)Subjects who have allergic reaction to drug medicine and food.
(9)Subjects who have systolic blood pressure less than 90 mmHg.
(10)Subjects who donated 200 mL or more of blood and/or blood components within the last one month prior to the current study.
(11)Male subjects who donated 400 mL or more of blood within the last three months prior to the current study.
(12)Female subjects who donated 400 mL or more of blood within the last four months prior to the current study.
(13)Male subjects whose blood was collected more than 1200 mL within the last twelve months when the amount of blood sampling in the current study is added.
(14)Female subjects whose blood was collected more than 800 mL within the last twelve months when the amount of blood sampling in the current study is added.
(15)Subjects who are participating in other clinical studies for drug medicine or food, or who finished clinical study within four weeks, or who are planning to participate in other clinical study.
(16)Subjects who are judged as unsuitable for the study by the principal investigator for other reasons.
Target sample size 60

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Keiichi Abe
Organization Suntory Global Innovation Center Limited
Division name Innovation Development Department
Zip code
Address 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto 619-0284
TEL 0774-66-1110
Email Keiichi_Abe@suntory.co.jp

Public contact
Name of contact person
1st name
Middle name
Last name Hiroshi Watanabe
Organization Suntory Global Innovation Center Limited
Division name Innovation Development Department
Zip code
Address 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto 619-0284
TEL 050-3182-0593
Homepage URL http://www.suntory.co.jp/sic/
Email H_Watanabe@suntory.co.jp

Sponsor
Institute Suntory Global Innovation Center Limited
Institute
Department

Funding Source
Organization National Agricultural and Food Research Organization
Organization
Division
Category of Funding Organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs YES
Study ID_1 13413790
Org. issuing International ID_1 National Agricultural and Food Research Organization
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions チヨダパラメディカルケアクリニック(東京都)

Other administrative information
Date of disclosure of the study information
2015 Year 12 Month 25 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 03 Month 19 Day
Date of IRB
Anticipated trial start date
2015 Year 05 Month 08 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2015 Year 05 Month 29 Day
Last modified on
2016 Year 01 Month 07 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020547

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.